Document:

Exhibit 10.1 - Amendment No. 1 to the Agreement and Plan of Merger

    
      

      

    

    

      FIRST
        AMENDMENT TO THE AGREEMENT AND

      PLAN
        OF MERGER

      

      This
        First Amendment the Agreement and Plan of Merger (the “Amendment”) is entered
        into as of October 4, 2006 to be effective as of August 23, 2006, by and
        among
        Solar Power, Inc., a California corporation (“SPI”) , Welund Fund, Inc., a
        Nevada corporation (the “Company”) and Welund Acquisition Corp., a Nevada
        corporation and a wholly-owned subsidiary of the Company (the “Merger Sub”).
        SPI, Company and Merger Sub also collectively referred to herein as the
“Parties.”

       

      RECITALS

      

      WHEREAS,
        SPI, the Company and the Merger Sub are parties to that certain Agreement
        and
        Plan of Merger dated August 23, 2006 (the “Merger Agreement”).

      

      WHEREAS,
        SPI, the Company and the Merger Sub desire to amend the Merger Agreement
        to
        extend the final date to November 30, 2006, or as otherwise extended by mutual
        consent thereafter.

      

      WHEREAS,
        the capitalized terms not otherwise defined herein shall have the meanings
        ascribed to them in the Merger Agreement

      

      AGREEMENT

      

      NOW,
        THEREFORE, in consideration of the foregoing premises, the mutual agreements
        set
        forth below, and other good and valuable consideration, the receipt and
        sufficiency of which is hereby acknowledged, the parties hereby agree as
        follows:

      

      1.
          Final
        Date.
        The
        last sentence of Section 10.1 of the Merger Agreement is hereby amended as
        follows:

      

      “As
        used
        herein, the “Final Date” shall be November 30, 2006 or as otherwise extended by
        mutual consent.”

      

      2.   Effect
        of Amendment.
        Except
        as expressly modified by the provisions hereof, the Merger Agreement is in
        all
        respects ratified and confirmed, and shall continue in full force and effect
        in
        accordance with its terms. To the extent that there are any inconsistencies
        between this Amendment and the Merger Agreement, the terms and provisions
        of
        this Amendment shall prevail.

      

      3.   Entire
        Agreement.
        The
        Merger Agreement and this Amendment, taken as a whole, shall supersede any
        and
        all agreements, either oral or written, between the Parties with respect
        to its
        subject matter. 

       

      4.   Counterparts.
        This
        Amendment may be executed in one or more counterparts (including by facsimile)
        each of which when so executed will be deemed an original and all of which,
        when
        taken together, will constitute one and the same agreement. 

       

      

      

      
        
           

        

        
          1

          
            

          

        

        
           

        

      

      

      IN
        WITNESS WHEREOF, the Parties have executed this Amendment as of the date
        first
        above written.

      

      

      
        	 	
                SOLAR
                  POWER, INC.,
                  a
                  California corporation

                 

              
	 	 
	 	
                By: /s/ Stephen
                  C.
                  Kircher                                                      
                  

              
	 	 
	 	
                Name:
                  Stephen
                  C.
                  Kircher                                                      
                  

              
	 	 
	 	
                Title:Chairman
                  and Chief Executive
                  Officer                             
                  

              
	 	 
	 	 
	 	
                WELUND
                  FUND, INC.,
                  a
                  Nevada corporation

                 

              
	 	 
	 	
                By:
                  /s/ Terrell
                  W.
                  Smith                                                           
                  

                 

              
	 	
                Name:
                  Terrell
                  W.
                  Smith                                                          
                  

                 

              
	 	
                Title:
                  Vice
                  President                                                                

                 

              
	 	 
	 	
                WELUND
                  ACQUISITION CORP.,
                  a
                  Nevada corporation

                 

              
	 	 
	 	
                By:
                  /s/ Terrell
                  W.
                  Smith                                                           
                  

                 

              
	 	
                Name:
                  Terrell
                  W.
                  Smith                                                          
                  

                 

              
	 	
                Title:
                  President                                                                        
                  

              

      

      
 

       

       

       

       

       

       

       

       

       

       2Exhibit 10.1

	
  

  	
   

  

 

August 1, 2006

Mr.
Mark Stolper

Primedex
Health Systems, Inc.

Chief Financial Officer

1510 Cotner Avenue

Los Angeles, CA 90025

Dear Mr. Stolper:

Engagement
and Services:

This
letter is to confirm our understanding of the services our firm, MorganFranklin
Corporation (“MorganFranklin” or “we”),
are to provide Primedex Health Systems, Inc. (“Primedex” or “you”) to assist you from time to time in the evaluation of
applicable accounting treatment, to provide support in the form of technical analysis related to accounting
and financial reporting matters that may arise, and to provide additional point of view regarding preliminary conclusions reached bay management
on certain matters.

We will endeavor to complete our
work within the time period determined by you and the engagement leader identified below. Although MorganFranklin
is not a public accounting firm, we will perform our work in accordance with Standards for Consulting Services
established by the American Institute of Certified Public Accountants (“AICPA”). Accordingly, we will provide no
opinion, attestation or other form of
assurance with respect to our work or the information upon which our work is
based. The procedures we will be performing will not constitute an examination
or a review in accordance with generally
accepted auditing standards or attestation standards. We will not audit or
otherwise verify the information
supplied to us in connection with this engagement, from whatever source, except
as may be specified in this
engagement letter.

It
is the Primedex’s responsibility to establish and maintain their internal
controls. In addition, it is the Company’s
responsibility to determine the
procedures deemed necessary in connection with your compliance with the provisions of the Act and
related Securities and Exchange Commission (SEC) rules, to execute those procedures and to assess the results of your procedures adequacy
thereof. We provide no opinion or other form of assurance with respect
to your compliance with the Act, related SEC rules, or your procedures. We make no representation as to
whether your procedures are sufficient for your purposes. Our services should not be taken to supplant inquiries and
procedures that the Company should undertake
for purposes of obtaining and using the information necessary in conjunction
with the Company’s compliance with
the provisions of the Act and related SEC rules.

You agree to provide us with all
documentation and information, access to computer systems, codes and software, and access to your employees and
consultants which we jointly agree to be necessary to complete our work. If we
believe that any failure to make reasonably requested information or persons

 1
 

 

available interferes with our
completing our work in accordance with the mutually agreed upon timeliness of
our engagement objectives, we will so notify you. In such event, you will not
hold us responsible and all fees and expenses will be paid to us in accordance
with the terms of the engagement.

Our services and advice will be
personal to you, and will be based, for the most part, on information that you
provide to MorganFranklin in the course of our engagement. Reports and other
deliverables, whether written or electronically produced, submitted by
MorganFranklin to Primedex (“Reports”) will be solely for Primedex’s benefit
and may not be relied upon by any third party. We will be available to review
our Reports with senior management, the audit committee the auditors of
Primedex and/or the board of directors of Primedex.

Staffing and Fees:

To ensure the highest
level of service and attention, Christopher Mann will serve as the engagement
leader and be responsible for our overall service delivery. He will report directly
to Mark Stolper, Chief Financial Officer. In addition to the engagement leader,
all of our clients are assigned a quality control officer who is kept informed
of engagement activities and assists in ensuring the highest quality of service
delivery, Sean Turner will serve as the quality control officer.

Services
for which you will be billed include time spent on research, analysis, document
review and drafting, correspondence, conferences, telephone calls, travel and
other services related to the engagement. We will ensure, to the greatest
extent possible, that the following people will service the account for the
duration of the engagement:

	
  MorganFranklin Personnel

  	
   

  	
  Standard 

  Monthly Rate

  	
   

  
	
  Christopher
  Mann, Engagement Leader

  	
   

  	
  $

  	
  275

  	
   

  
	
  Sean Turner, Quality
  Control Officer

  	
   

  	
  $

  	
  275

  	
   

  
	
  Director, TBD

  	
   

  	
  $

  	
  250

  	
   

  
	
  Senior Manager, TBD

  	
   

  	
  $

  	
  235

  	
   

  
	
  Manager, TBD

  	
   

  	
  $

  	
  215

  	
   

  
	
  Senior Associate, TBD

  	
   

  	
  $

  	
  195

  	
   

  
	
  Associate, TBD

  	
   

  	
  $

  	
  140

  	
   

  

 

If, for whatever reason, additional MorganFranklin
personnel are required, the applicable rates will be addressed and agreed upon
prior to the additional personnel commencing fieldwork on the eagagement.

 2
 

 

Our performance of services may involve direct and
indirect costs that we will incur on your behalf. These disbursements and
charges include items incurred and paid by us on your behalf such as long
distance telephone charges, postage, special mail or delivery charges,
transportation, meals, lodging and other costs necessary for out-of-town
travel, photocopying, and use of other service providers such as printers or
experts, if needed. These charges may include the actual costs plus
administrative charges which cover our services and costs for advancing funds.

In the event
MorganFranklin or its personnel are required pursuant to subpoens or other
legal process to produce documents or provide testimony relating to this
engagement in any administrative or judicial or quasi-judicial proceeding to
which MorganFranklin is not a party, Primedex shall reimburse MorganFranklin
for its professional time and expenses, including reasonable attorneys’ fees,
incurred in responding to such request.

We will invoice monthly,
payable net 30 days. Payment should be made in U.S. dollars, in checks or
drafts payable to “MorganFranklin Corporation,” or via electronic transfer.
Point of contact for all billing related matters is Teresa Otero at

703-564-7525 ext 250 or oterot@morgan-franklin.com.

Limitations:

Our services will be
rendered in good faith by qualified personnel and our reports will be based
upon our good faith business and professional judgment. Accounting principles
and their application vary from industry-to-industry, and the application of
various accounting principles is often based upon facts and circumstances.
Similarly, internal controls systems and procedures are often specially
designed and implemented. The in-depth evaluation of internal controls is
relatively new, and testing procedures continue to evolve. Unless expressly
engaged for such purpose by Primedex, MorganFranklin will not be responsible
for identifying material weaknesses significant deficiencies in internal
controls, or identifying material errors, fraud or illegal acts. However, if
any such matters come to our attention in the course of our work, we will so
notify the appropriate Company representative(s). 

MorganFranklin makes no
other representation or warranty regarding either its services or Reports; any
express or implied warranties arising from custom of usage in the accounting
profession and warranties arising by operation of law are expressly disclaimed.
Accordingly, (1) there can be no assurance that Primedex’s independent
auditors, financial institutions, governmental agencies (including without
limitation, the SEC) or any self-regulatory organization (e.g., securities
exchange) will not challenge, perhaps successfully, financial reporting
positions taken by Primedex after considering our Reports; (2) Primedex agrees
that neither MorganFranklin, nor any of its personnel shall be liable, accountable
or responsible, in damages or otherwise, to Primedex or its successors and
assigns for any loss, damages, liability costs, or expense incurred or
sustained that are attributable to any financial reporting position taken by
Primedex in reliance upon MorganFranklin’s Reports; (3) Primedex shall
indemnify, defend and hold harmless MorganFranklin and its personnel from and
against any loss, liability, damage, cost or expense (including reasonable
attorney’s fees) sustained or incurred as a result of any act or omission by
Primedex, whether or not in reliance upon MorganFranklin reports.

 

 3
 

 

The
foregoing shall not limit MorganFranklin’s liability or responsibility for its
own gross negligence or willful misconduct.

In no
event will MorganFranklin be liable for special, punitive, incidental or
consequential damages even if we have bean advised of the possibility of such
damages. Our maximum liability to Primedex, whether in tort, contracts, or
otherwise, is limited to the amount of fees paid to us for our services under
this engagement:

Dispute Resolution:

Any
controversy or claim arising out of, or relating to the services covered by
this letter or hereafter provided to
Primedex shall be submitted first to voluntary mediation and, if mediation is
not successful, then to binding
arbitration. Such arbitration proceedings shall be conducted under the rules then prevailing of the American
Arbitration Association in the city where this letter is signed by Primedex.
The judgment or award of the arbitrators shall be binding and conclusive upon
MorganFranklin and Primedex and may be entered in any court of competent
jurisdiction.

We
appreciate the opportunity to be of service to you and believe this letter
accurately summarizes the significant
terms of our engagement. If you have any questions, please let us know. If you
agree with the terms of our engagement as
described in this letter, please sign and return to us the enclosed copy
of this letter.

Very truly yours,

	
  /s/ Christopher Mann

  	
   

  
	
  Christopher Mann

  Senior Vice President-FAS

  

 

 4
 

 

RESPONSE:

This letter correctly sets forth our understanding of the terms of your
engagement.

Primedex Health Systems Inc.:

	
  /s/ Mark D. Stolper

  	
   

  
	
  Officer signature

  
	
   

  
	
  Chief Financial
  Officer

  	
   

  
	
  Title

  
	
   

  
	
  8/23/06

  	
   

  
	
  Date

  
			

 

This letter is to confirm our understanding of the services of our
firm, MorganFranklin Corporation (“we”), are to provide (“Primedex” or “you”)
to assist you in:

 5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00111-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00111-of-00352.parquet"}]]